Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

GEFT Activators

GEFT, or Rho guanine nucleotide exchange factor 25, activators belong to a distinct chemical class that plays a pivotal role in cellular signaling pathways. These activators exert their influence on the Rho family of small GTPases, specifically targeting the RhoA protein. Rho GTPases are critical molecular switches that regulate various cellular processes, including cytoskeletal dynamics, cell migration, and gene expression. GEFT activators are characterized by their ability to modulate the activity of RhoA by promoting the exchange of guanosine diphosphate (GDP) for guanosine triphosphate (GTP) on the RhoA protein. This activation of RhoA, in turn, triggers downstream signaling cascades that impact cellular functions.

Structurally, GEFT activators often possess unique chemical motifs that facilitate their interaction with RhoA and promote nucleotide exchange. The activation of RhoA by GEFT activators contributes to the intricate regulation of cellular morphology and motility. These small molecules serve as molecular switches themselves, fine-tuning the balance between active and inactive states of RhoA. The intricate interplay between GEFT activators and the RhoA GTPase highlights the complexity of cellular signaling networks. Understanding the mechanisms by which these activators influence cellular processes at the molecular level provides valuable insights into the fundamental biology of cell regulation and opens avenues for further exploration of their physiological roles.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Lysophosphatidic Acid

325465-93-8sc-201053
sc-201053A
5 mg
25 mg
$98.00
$341.00
50
(3)

GPCR agonist, may activate downstream signaling cascades, potentially activating Rho GTPases and GEFT.

Dasatinib

302962-49-8sc-358114
sc-358114A
25 mg
1 g
$70.00
$145.00
51
(1)

Inhibits Src kinase, a potential upstream regulator of Rho GTPases, suggesting an indirect activation mechanism for GEFT.

Y-27632, free base

146986-50-7sc-3536
sc-3536A
5 mg
50 mg
$186.00
$707.00
88
(1)

Inhibition of ROCK, a downstream effector of Rho GTPases, may indirectly activate Rho signaling pathways and potentially activate GEFT.

Sodium Orthovanadate

13721-39-6sc-3540
sc-3540B
sc-3540A
5 g
10 g
50 g
$49.00
$57.00
$187.00
142
(4)

Inhibition of protein tyrosine phosphatases (PTPs) by Sodium Orthovanadate may indirectly enhance Rho GTPase activity, suggesting a potential activation mechanism for GEFT.

A23187

52665-69-7sc-3591
sc-3591B
sc-3591A
sc-3591C
1 mg
5 mg
10 mg
25 mg
$55.00
$131.00
$203.00
$317.00
23
(1)

A23187, a calcium ionophore, can modulate intracellular calcium levels, potentially activating Rho signaling pathways and indirectly activating GEFT.

N-Acetyl-L-cysteine

616-91-1sc-202232
sc-202232A
sc-202232C
sc-202232B
5 g
25 g
1 kg
100 g
$34.00
$74.00
$270.00
$114.00
34
(1)

NAC, as an antioxidant, might activate Rho GTPases by modulating reactive oxygen species (ROS), potentially activating GEFT indirectly.

Methyl-β-cyclodextrin

128446-36-6sc-215379A
sc-215379
sc-215379C
sc-215379B
100 mg
1 g
10 g
5 g
$20.00
$48.00
$160.00
$82.00
19
(1)

Disruption of lipid rafts by Methyl-β-Cyclodextrin could affect the localization and activity of Rho GTPases, potentially activating GEFT indirectly.

PMA

16561-29-8sc-3576
sc-3576A
sc-3576B
sc-3576C
sc-3576D
1 mg
5 mg
10 mg
25 mg
100 mg
$41.00
$132.00
$214.00
$500.00
$948.00
119
(6)

PMA, as an activator of PKC, may modulate Rho GTPase activity, suggesting an indirect activation mechanism for potential GEFT activation.

Forskolin

66575-29-9sc-3562
sc-3562A
sc-3562B
sc-3562C
sc-3562D
5 mg
50 mg
1 g
2 g
5 g
$78.00
$153.00
$740.00
$1413.00
$2091.00
73
(3)

Forskolin increases intracellular cAMP levels, potentially activating Rho GTPase signaling and suggesting an indirect activation mechanism for GEFT.

AEBSF hydrochloride

30827-99-7sc-202041
sc-202041A
sc-202041B
sc-202041C
sc-202041D
sc-202041E
50 mg
100 mg
5 g
10 g
25 g
100 g
$65.00
$122.00
$428.00
$851.00
$1873.00
$4994.00
33
(1)

AEBSF, a protease inhibitor, may impact signaling cascades involving proteases, indirectly affecting Rho GTPases and potentially activating GEFT.